ArticleBMC neurology2017

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study.

Chiara Zecca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.